10-Q quarterly report · filed Nov 4, 2026

PROCEPT BioRobotics Corp (PRCT) Q3 2026 10-Q Quarterly Report

Short answer

PROCEPT BioRobotics Corp (PRCT) filed its Q3 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $98M (up 18.0% year over year) with net income of −$27M.

Q3 2026 key financials · XBRL

Revenue
$98M
+18.0% YoY · +4.0% QoQ
Net income
−$27M
−23.8% YoY · +1.3% QoQ
Operating margin
-27.9%
Gross margin
66.3%
EPS (diluted)
−$0.46
−17.9% YoY · +2.1% QoQ

Source: XBRL data from the PROCEPT BioRobotics Corp (PRCT) Q3 2026 10-Q on SEC EDGAR. USD.

PROCEPT BioRobotics Corp Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Quarterly revenue $98.3M, up 18% YoY from $83.3M
  • Gross margin 66% vs 65% YoY, including $3.2M tariff refunds
  • Best line handpieces and consumables $60.8M, up from $49.7M; weakest systems $29.2M vs $28.1M
  • Operating cash flow $(66.4)M for nine months vs $(38.7)M; investing outflow $6.5M
  • Cash $218.4M; management expects funding through at least the next twelve months, with higher sales, marketing and R&D spending ahead

Risk Factors

  • No material changes to previously disclosed risk factors during nine months ended September 30, 2026
  • Healthcare industry risks remain relevant to business, financial condition, and operating results
  • Unknown or currently immaterial risks could materially adversely affect results
  • Historical financial performance may not reliably indicate future results

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other PROCEPT BioRobotics Corp quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.